Immunomodulatory Nonstructural Proteins of Influenza A Viruses

Trends in Microbiology

Volumn 26, Issue 7, 2018, Pages 624-636

  Klemm, Carolin ^a   Boergeling, Yvonne ^a   Ludwig, Stephan ^a   Ehrhardt, Christina ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

host interaction partners; influenza virus; interferon response

Indexed keywords

INTERFERON; NONSTRUCTURAL PROTEIN 1; PA X PROTEIN; PB1 F2 PROTEIN; UNCLASSIFIED DRUG; VIRAL PROTEIN; ANTIVIRUS AGENT; DDX58 PROTEIN, HUMAN; INFLUENZA VIRUS POLYMERASE BASIC PROTEIN 1; INS1 PROTEIN, INFLUENZA VIRUS; PA-X PROTEIN, INFLUENZA A VIRUS; PB1-F2 PROTEIN, INFLUENZA A VIRUS; REPRESSOR PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I;

ANTIVIRAL ACTIVITY; CYTOKINE RELEASE; IMMUNOMODULATION; INFLUENZA A; INFLUENZA A VIRUS; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS VIRULENCE; DRUG EFFECT; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INFLUENZA; METABOLISM; SIGNAL TRANSDUCTION; VIROLOGY;

ANTIVIRAL AGENTS; DEAD BOX PROTEIN 58; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 85040554712     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2017.12.006     Document Type: Review

References (101)

1. Taubenberger, J.K., Morens, D.M., Influenza: the once and future pandemic. Public Health Rep. 125:Suppl. 3 (2010), 16–26.
2. Vasin, A.V., et al. Molecular mechanisms enhancing the proteome of influenza A viruses: an overview of recently discovered proteins. Virus Res. 185 (2014), 53–63.
3. Noda, T., Kawaoka, Y., Structure of influenza virus ribonucleoprotein complexes and their packaging into virions. Rev. Med. Virol. 20 (2010), 380–391.
4. Hale, B.G., et al. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89 (2008), 2359–2376.
5. Chakrabarti, A.K., Pasricha, G., An insight into the PB1F2 protein and its multifunctional role in enhancing the pathogenicity of the influenza A viruses. Virology 440 (2013), 97–104.
6. Shaw, M.L., Stertz, S., Role of host genes in influenza virus replication. Curr. Top. Microbiol. Immunol., 2017, 10.1007/82_2017_30 Published online June 23, 2017.
7. Edinger, T.O., et al. Entry of influenza A virus: host factors and antiviral targets. J. Gen. Virol. 95 (2014), 263–277.
8. Pohl, M.O., et al. Late stages of the influenza A virus replication cycle-a tight interplay between virus and host. J. Gen. Virol. 97 (2016), 2058–2072.
9. Iwasaki, A., Pillai, P.S., Innate immunity to influenza virus infection. Nat. Rev. Immunol. 14 (2014), 315–328.
10. Parker, D., Impact of type I and III interferons on respiratory superinfections due to multidrug-resistant pathogens. J. Infect. Dis. 215 (2017), S58–S63.
11. Fensterl, V., Sen, G.C., Interferons and viral infections. Biofactors 35 (2009), 14–20.
12. Takeuchi, O., Akira, S., Pattern recognition receptors and inflammation. Cell 140 (2010), 805–820.
13. Crotta, S., et al. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog., 9, 2013, e1003773.
14. Firth, A.E., Brierley, I., Non-canonical translation in RNA viruses. J. Gen. Virol. 93 (2012), 1385–1409.
15. Khoury, G.A., et al. Proteome-wide post-translational modification statistics: frequency analysis and curation of the Swiss-Prot database. Sci. Rep., 2011, 10.1038/srep00090 Published online September 13, 2011.
16. Hutchinson, E.C., et al. Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry. PLoS Pathog., 8, 2012, e1002993.
17. Pal, S., et al. Influenza A virus interacts extensively with the cellular SUMOylation system during infection. Virus Res. 158 (2011), 12–27.
18. Tang, Y., et al. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J. Immunol. 184 (2010), 5777–5790.
19. Baez, M., et al. Complete nucleotide sequence of the influenza A/PR/8/34 virus NS gene and comparison with the NS genes of the A/Udorn/72 and A/FPV/Rostock/34 strains. Nucleic Acids Res. 8 (1980), 5845–5858.
20. Huang, X., et al. An NS-segment exonic splicing enhancer regulates influenza A virus replication in mammalian cells. Nat. Commun., 8, 2017, 14751.
21. Hale, B.G., et al. Structure of an avian influenza A virus NS1 protein effector domain. Virology 378 (2008), 1–5.
22. Hale, B.G., Conformational plasticity of the influenza A virus NS1 protein. J. Gen. Virol. 95 (2014), 2099–2105.
23. Melén, K., et al. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J. Virol. 81 (2007), 5995–6006.
24. Li, Y., et al. Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 4864–4869.
25. Hutchinson, E.C., et al. Conserved and host-specific features of influenza virion architecture. Nat. Commun., 5, 2014, 4816.
26. Bergmann, M., et al. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74 (2000), 6203–6206.
27. Marc, D., Influenza virus non-structural protein NS1: interferon antagonism and beyond. J. Gen. Virol. 95 (2014), 2594–2611.
28. Mibayashi, M., et al. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J. Virol. 81 (2007), 514–524.
29. Jureka, A.S., et al. Structural basis for a novel interaction between the NS1 protein derived from the 1918 influenza virus and RIG-I. Structure 23 (2015), 2001–2010.
30. Gack, M.U., et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5 (2009), 439–449.
31. Rajsbaum, R., et al. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog., 8, 2012, e1003059.
32. Min, J.Y., Krug, R.M., The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 7100–7105.
33. Min, J.Y., et al. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363 (2007), 236–243.
34. Tawaratsumida, K., et al. Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor. J. Virol. 88 (2014), 9038–9048.
35. Feng, W., et al. Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response. Biochem. Biophys. Res. Commun. 482 (2017), 1107–1113.
36. Nacken, W., et al. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses. Biol. Chem. 393 (2012), 525–534.
37. Nacken, W., et al. Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1. J. Virol. 88 (2014), 8843–8852.
38. Rückle, A., et al. The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-kappaB pathway and p52/RelB-dependent gene expression in lung epithelial cells. J. Virol. 86 (2012), 10211–10217.
39. Gao, S., et al. Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. Cell. Microbiol. 14 (2012), 1849–1866.
40. Marazzi, I., et al. Suppression of the antiviral response by an influenza histone mimic. Nature 483 (2012), 428–433.
41. Noah, D.L., et al. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307 (2003), 386–395.
42. Anastasina, M., et al. Influenza virus NS1 protein binds cellular DNA to block transcription of antiviral genes. Biochim. Biophys. Acta 1859 (2016), 1440–1448.
43. Hale, B.G., et al. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 14194–14199.
44. Lopes, A.M., et al. Structure-guided functional annotation of the influenza A virus NS1 protein reveals dynamic evolution of the p85beta-binding site during circulation in humans. J. Virol., 91, 2017, e01081-17.
45. Hrincius, E.R., et al. A single point mutation (Y89F) within the non-structural protein 1 of influenza A viruses limits epithelial cell tropism and virulence in mice. Am. J. Pathol. 180 (2012), 2361–2374.
46. Fan, S., et al. Synergistic effect of the PDZ and p85beta-binding domains of the NS1 protein on virulence of an avian H5N1 influenza A virus. J. Virol. 87 (2013), 4861–4871.
47. Ylösmäki, L., et al. Reorganization of the host cell Crk(L)-PI3 kinase signaling complex by the influenza A virus NS1 protein. Virology 484 (2015), 146–152.
48. Ylösmäki, L., et al. Nuclear translocation of Crk adaptor proteins by the influenza A virus NS1 protein. Viruses, 8, 2016, 101.
49. de Chassey, B., et al. The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication. PLoS Pathog., 9, 2013, e1003440.
50. Kuo, R.L., et al. Interactome analysis of the NS1 protein encoded by influenza A H1N1 virus reveals a positive regulatory role of host protein PRP19 in viral replication. J. Proteome Res. 15 (2016), 1639–1648.
51. Pereira, C.F., et al. Influenza A virus NS1 protein promotes efficient nuclear export of unspliced viral M1 mRNA. J. Virol., 2017, 10.1128/JVI. 00528-17 Published online May 17, 2017.
52. Thulasi Raman, S.N., Zhou, Y., Networks of host factors that interact with NS1 protein of influenza A virus. Front. Microbiol., 7, 2016, 654.
53. Mahmoudian, S., et al. Influenza A virus proteins PB1 and NS1 are subject to functionally important phosphorylation by protein kinase C. J. Gen. Virol. 90 (2009), 1392–1397.
54. Hirata, N., et al. Inhibition of Akt kinase activity suppresses entry and replication of influenza virus. Biochem. Biophys. Res. Commun. 450 (2014), 891–898.
55. Matsuda, M., et al. Characterization of the interaction of influenza virus NS1 with Akt. Biochem. Biophys. Res. Commun. 395 (2010), 312–317.
56. Hsiang, T.Y., et al. Roles of the phosphorylation of specific serines and threonines in the NS1 protein of human influenza A viruses. J. Virol. 86 (2012), 10370–10376.
57. Hale, B.G., et al. CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology 383 (2009), 6–11.
58. Kathum, O.A., et al. Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activity. Cell. Microbiol. 18 (2016), 784–791.
59. Pal, S., et al. Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the Small Ubiquitin-like MOdifier by the use of dicistronic expression constructs. J. Virol. Methods 163 (2010), 498–504.
60. Xu, K., et al. Modification of nonstructural protein 1 of influenza A virus by SUMO1. J. Virol. 85 (2011), 1086–1098.
61. Santos, A., et al. SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization. J. Virol. 87 (2013), 5602–5620.
62. Zhao, C., et al. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 2253–2258.
63. Chen, W., et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7 (2001), 1306–1312.
64. Zamarin, D., et al. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog., 1, 2005, e4.
65. Kash, J.C., et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443 (2006), 578–581.
66. Dudek, S.E., et al. The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol. Chem. 392 (2011), 1135–1144.
67. Mazur, I., et al. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell. Microbiol. 10 (2008), 1140–1152.
68. McAuley, J.L., et al. The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J. Virol. 84 (2010), 558–564.
69. McAuley, J.L., et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2 (2007), 240–249.
70. Yoshizumi, T., et al. Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity. Nat. Commun., 5, 2014, 4713.
71. Chen, C.J., et al. Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J. Virol. 84 (2010), 10051–10062.
72. Cheng, Y.Y., et al. Amino acid residues 68-71 contribute to influenza A virus PB1-F2 protein stability and functions. Front. Microbiol., 8, 2017, 692.
73. Conenello, G.M., et al. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3 (2007), 1414–1421.
74. Vidic, J., et al. Amyloid assemblies of influenza A virus PB1-F2 protein damage membrane and induce cytotoxicity. J. Biol. Chem. 291 (2016), 739–751.
75. Ajjaji, D., et al. N-terminal domain of PB1-F2 protein of influenza A virus can fold into amyloid-like oligomers and damage cholesterol and cardiolipid containing membranes. Biochem. Biophys. Res. Commun. 477 (2016), 27–32.
76. Varga, Z.T., et al. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog., 7, 2011, e1002067.
77. Leymarie, O., et al. Influenza virus protein PB1-F2 interacts with CALCOCO2 (NDP52) to modulate innate immune response. J. Gen. Virol. 98 (2017), 1196–1208.
78. Shin, N., et al. Influenza A virus PB1-F2 is involved in regulation of cellular redox state in alveolar epithelial cells. Biochem. Biophys. Res. Commun. 459 (2015), 699–705.
79. Vidy, A., et al. The influenza virus protein PB1-F2 increases viral pathogenesis through neutrophil recruitment and NK cells inhibition. PLoS One, 11, 2016, e0165361.
80. Mitzner, D., et al. Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell. Microbiol. 11 (2009), 1502–1516.
81. Kosik, I., et al. The ubiquitination of the influenza A virus PB1-F2 protein is crucial for its biological function. PLoS One, 10, 2015, e0118477.
82. Jagger, B.W., et al. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337 (2012), 199–204.
83. Shi, M., et al. Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A virus. J. Virol. 86 (2012), 12411–12413.
84. Bavagnoli, L., et al. The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA. Nucleic Acids Res. 43 (2015), 9405–9417.
85. Khaperskyy, D.A., et al. Selective degradation of host RNA polymerase II transcripts by influenza A virus PA-X host shutoff protein. PLoS Pathog., 12, 2016, e1005427.
86. Gao, H., et al. The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses. Sci. Rep., 5, 2015, 8262.
87. Hu, J., et al. PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response. J. Virol. 89 (2015), 4126–4142.
88. Gao, H., et al. PA-X is a virulence factor in avian H9N2 influenza virus. J. Gen. Virol. 96 (2015), 2587–2594.
89. Hayashi, T., et al. Influenza A virus protein PA-X contributes to viral growth and suppression of the host antiviral and immune responses. J. Virol. 89 (2015), 6442–6452.
90. Lee, J., et al. Impacts of different expressions of PA-X protein on 2009 pandemic H1N1 virus replication, pathogenicity and host immune responses. Virology 504 (2017), 25–35.
91. Söderholm, S., et al. Multi-omics studies towards novel modulators of influenza A virus-host interaction. Viruses, 8, 2016, 269.
92. Boergeling, Y., et al. Evidence for a novel mechanism of influenza virus-induced type I Interferon expression by a defective RNA-encoded protein. PLoS Pathog., 11, 2015, e1004924.
93. Wise, H.M., et al. A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J. Virol. 83 (2009), 8021–8031.
94. Muramoto, Y., et al. Identification of novel influenza A virus proteins translated from PA mRNA. J. Virol. 87 (2013), 2455–2462.
95. Lamb, R.A., et al. Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc. Natl. Acad. Sci. U. S. A. 78 (1981), 4170–4174.
96. Shih, S.R., et al. A novel spliced transcript of influenza A/WSN/33 virus. Virus Genes 17 (1998), 179–183.
97. Wise, H.M., et al. Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog., 8, 2012, e1002998.
98. Engel, D.A., The influenza virus NS1 protein as a therapeutic target. Antiviral Res. 99 (2013), 409–416.
99. Selman, M., et al. Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing. Emerg. Microbes Infect., 1, 2012, e42.
100. Zhirnov, O.P., et al. Segment NS of influenza A virus contains an additional gene NSP in positive-sense orientation. Dokl. Biochem. Biophys. 414 (2007), 127–133.
101. Clifford, M., et al. Evidence for a novel gene associated with human influenza A viruses. Virol. J., 6, 2009, 198.